Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia

Authors: Pryka R.¹; Kowalsky S.; Haverstock D.

Source: Clinical Therapeutics, Volume 20, Number 1, January 1998 , pp. 141-155(15)

Publisher: Elsevier

Keywords: ciprofloxacin 750 mg; lower respiratory tract infection; pneumonia; acute exacerbations of chronic bronchitis

Language: English

Document Type: Research article

DOI: 10.1016/S0149-2918(98)80041-6

Affiliations: 1: Bayer Corporation, Pharmaceutical Division, West Haven, Connecticut, U.S.A.

Links for this article

http://www.ingentaconnect.com/els/01492918/1998/00000020/00000001/art80041
http://openurl.ingenta.com/content?genre=article&issn=0149-2918&volume=20&issue=1&spage=141&epage=155
http://dx.doi.org/10.1016/S0149-2918(98)80041-6